Remote Strategic BD Leader — Diagnostics & Biopharma

GOEBEL FIXTURE COMPANY; United States; Remote; USD 110,000 - 170,000; Full time

Benefits offered by this job

Medical and dental insurance

Health Savings Account

Life insurance and disability coverage

401k with company match

Tuition reimbursement and professional

Job summary

Microbiologics is seeking a Business Development Manager to drive growth across diagnostics and biopharma R&D markets. You will identify opportunities, grow key accounts, and translate market needs into business results.

The role emphasizes strategic planning, cross-functional collaboration, and revenue growth while operating remotely with up to 50% travel, supporting a global biotechnology leader.

Qualifications

• Bachelor’s degree required, advanced degree preferred.
• 10 years of related experience in business development or sales.
• 4+ years in medical device, microbiology diagnostics, or related sales.
• Experience in growing key accounts and developing strategic sales plans.
• Ability to analyze markets, competition, and pricing to guide decisions.

Responsibilities

• Establish new accounts and grow key corporate accounts across diagnostics and biopharma R&D markets.
• Identify and pursue new business opportunities aligned with strengths and value proposition.
• Develop and execute strategic account and market plans.
• Develop and execute business plans and sales strategies to meet revenue goals.
• Lead cross functional collaboration with Marketing, R&D, and Operations.

Skills

Business development

Key account management

Market analysis

Strategic sales planning

Cross-functional collaboration

Education

Bachelor's degree

Job description

Microbiologics is seeking a Business Development Manager to drive growth across diagnostics and biopharma R&D markets. You will identify opportunities, grow key accounts, and translate market needs into business results.

The role emphasizes strategic planning, cross-functional collaboration, and revenue growth while operating remotely with up to 50% travel, supporting a global biotechnology leader.